Results 41 to 50 of about 18,187,223 (191)
How I Diagnose Angioimmunoblastic T-Cell Lymphoma [PDF]
OBJECTIVES: Angioimmunoblastic T-cell lymphoma (AITL) is a subtype of peripheral T-cell lymphoma derived from T-follicular helper cells. For pathologists, diagnosing AITL may be challenging due to its wide clinical and histopathologic spectrum, which can
Jaffe, Elaine S +3 more
core +1 more source
Unravelling Subtleties of Angioimmunoblastic T-Cell Lymphoma [PDF]
International ...
Bachy, Emmanuel, Salles, Gilles
openaire +3 more sources
PCR-based clonality detection in angioimmunoblastic T-cell lymphoma
In this article, we discuss the issues of angioimmunoblastic T-cell lymphoma diagnosis, particularly the PCR-based methods of clonality detection. Assessments of T-and B-cell clonality was based on TCRG (Vg-Jg), TCRB (Vb-Jb, Db-Jb), IGH (FR1, FR2, and ...
Yu. V. Sidorova +7 more
doaj +1 more source
Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma
CTLA4 and CD28 are co-regulatory receptors with opposite roles in T-cell signaling. By RNA sequencing, we identified a fusion between the two genes from partial gene duplication in a case of angioimmunoblastic T-cell lymphoma.
Hae Yong Yoo +11 more
doaj +1 more source
Recent Advances in Diagnosis and Therapy of Angioimmunoblastic T Cell Lymphoma
Angioimmunoblastic T cell lymphoma (AITL) is a common subtype of mature peripheral T cell lymphoma (PTCL). As per the 2016 World Health Organization classification, AITL is now considered as a subtype of nodal T cell lymphoma with follicular helper T ...
Mostafa F. Mohammed Saleh +5 more
doaj +1 more source
Pleuropneumonia Revealing Angioimmunoblastic T-cell Lymphoma. [PDF]
Angioimmunoblastic T-cell lymphoma (AITL) is a rare form of lymphoma that presents with a wide range of symptoms, including multiple lymphadenopathies, systemic symptoms, splenomegaly, hepatomegaly, and skin rashes. Due to its atypical presentation, diagnosis can be delayed, and confirmation relies on lymph node biopsy.
Salhi Z +7 more
europepmc +3 more sources
A phase IIa study of the anti‐PD‐L1 antibody avelumab in relapsed/refractory PTCL: The AVAIL‐T trial
The AVAIL‐T study, the first evaluation of programmed death ligand 1 (PD‐L1) blockade in relapsed/refractory peripheral T‐cell lymphomas (PTCL), demonstrated limited single agent activity with durable responses seen in a minority. Circulating tumour DNA revealed distinct mutational dynamics and mass cytometry identified perturbed T‐cell subsets ...
Matthew J. Ahearne +28 more
wiley +1 more source
The curious origins of angioimmunoblastic T-cell lymphoma [PDF]
Purpose of review Once an obscure disease, recent studies have transformed our understanding of angioimmunoblastic T-cell lymphoma (AITL). In this review, we summarize new major advances in the genetics and biology of AITL.
José R, Cortés, Teresa, Palomero
openaire +2 more sources
Mycosis Fungoides Associated with Kaposi's Sarcoma, T-cell Rich B-cell Lymphoma, and T cell Lymphoma with Angioimmunoblastic Features [PDF]
A patient with mycosis fungoides (MF), Kaposi's sarcoma, T-cell B-cell rich lymphoma and T-cell lymphoma with angioimmunoblastic features is described. The appearance of multiple malignancies in this patient may have been caused by previous exposure to ...
Gat, Andrea +4 more
core +1 more source
Abstract Autoimmune haemolytic anaemia is a rare immune‐mediated disorder leading to accelerated red cell destruction and anaemia. There is considerable clinical heterogeneity, with some patients barely requiring intervention, while others experience fulminant haemolysis and experience mortality rates as high as 30% with severe anaemia and end‐organ ...
Philip Choi +9 more
wiley +1 more source

